Human mitochondrial carnitine-acyl carnitine cycle disorders cause inherited disorders such as CACT, CPT2, and LCAD deficiencies, resulting in impaired fatty acid β-oxidation and elevated serum ACs levels. Here, CPT2 is linked to long chain acyl-CoA dehydrogenase deficiency.